At 11:00 am, Sun Pharma shares have been buying and selling at Rs 672.20, down 4.2 per cent, on the BSE.
Sun Pharma shares slid greater than 4 per cent to Rs 676 in a agency market a day after the pharma firm posted its March quarter outcomes. Sun Pharma posted a internet revenue to Rs 894 crore within the fourth quarter ended March 2021, which is an increase of 124 per cent in comparison with the identical quarter final yr. At 11:00 am, Sun Pharma shares have been buying and selling at Rs 672.20, down 4.2 per cent, on the BSE.
The firm’s consolidated gross sales from operations got here in at Rs 8,431 crore, up 4.4 per cent over the corresponding quarter of the earlier yr.
The earnings earlier than curiosity, taxes, depreciation and amortisation (Ebitda) within the quarter into consideration have been Rs 1,956.8 crore, up 56 per cent over final yr’s corresponding quarter.
The BSE Sensex and NSE Nifty have been greater by 0.4 per cent on the time.
